2025
SJR Q4
JCR Q4 · 0,7
OA
63 matched articles
SCIE
Journal detail
Bangladesh Journal of Pharmacology
- Publisher
- Bangladesh Pharmacological Society
- Country
- Bangladesh · Asiatic Region
- Type
- journal
- ISSN
-
1991007X19910088
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,17
- Quartile Q4
- H-Index 34
- Cites/doc 0,63
- Docs (3y) 60
- Cites (3y) 36
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,7
- 5Y JIF 0,7
- JCI 0,2
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q4
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q4 | Q4 | 0,17 | 0,7 | 0,7 | 0,2 | Q4 | 34 |
| 2024 | Q3 | Q4 | 0,248 | 0,9 | 0,9 | 0,28 | Q4 | 32 |
| 2023 | Q4 | Q4 | 0,214 | 0,9 | 1 | 0,29 | Q4 | 32 |
| 2022 | Q3 | Q4 | 0,246 | 1,6 | 1,6 | 0,31 | Q4 | 32 |
| 2021 | Q4 | Q4 | 0,24 | 1,1 | 1,2 | 0,25 | Q4 | 32 |
| 2020 | Q3 | Q4 | 0,385 | 0,9 | 1 | 0,33 | Q4 | 32 |
| 2019 | Q3 | Q4 | 0,337 | 1,3 | 0,8 | 0,3 | Q4 | 32 |
| 2018 | — | Q4 | — | 0,8 | 0,7 | 0,28 | Q4 | — |
| 2017 | Q3 | Q4 | 0,466 | 0,8 | 0,8 | 0,31 | Q4 | 32 |
| 2016 | Q3 | Q4 | 0,319 | 0,6 | 0,6 | — | — | 32 |
| 2015 | Q3 | Q4 | 0,273 | 0,7 | 0,7 | — | — | 32 |
| 2014 | Q3 | Q4 | 0,369 | 1,1 | 1 | — | — | 32 |
| 2013 | Q3 | Q4 | 0,245 | 0,5 | 0,8 | — | — | 32 |
| 2012 | Q3 | Q4 | 0,253 | 0,4 | — | — | — | 32 |
| 2011 | Q3 | Q4 | 0,393 | 0,6 | — | — | — | 32 |
| 2010 | Q2 | Q4 | 0,497 | 0,7 | — | — | — | 32 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 333/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 312/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 309/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 242/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 260/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 261/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 239/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 246/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 240/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 245/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 235/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 215/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 227/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 243/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 232/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 209/252 |